• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Evoqua Water Technologies Corp. (Amendment)

    1/31/23 9:19:10 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials
    Get the next $AQUA alert in real time by email
    SC 13G/A 1 us30057t1051_013123.txt us30057t1051_013123.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 5) EVOQUA WATER TECHNOLOGIES CORP -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 30057T105 -------------------------------------------------------- (CUSIP Number) December 31, 2022 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 30057T105 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 11771294 (6) Shared voting power 0 (7) Sole dispositive power 12787375 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 12787375 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 10.5% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- EVOQUA WATER TECHNOLOGIES CORP Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 210 SIXTH AVENUE PITTSBURGH PA 15222 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 55 East 52nd Street New York, NY 10055 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) CUSIP No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 12787375 Percent of class 10.5% Number of shares as to which such person has: Sole power to vote or to direct the vote 11771294 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 12787375 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of EVOQUA WATER TECHNOLOGIES CORP. No one person's interest in the common stock of EVOQUA WATER TECHNOLOGIES CORP is more than five percent of the total outstanding common shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 31, 2023 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary BlackRock Life Limited Aperio Group, LLC BlackRock Advisors, LLC BlackRock (Netherlands) B.V. BlackRock Institutional Trust Company, National Association BlackRock Asset Management Ireland Limited BlackRock Financial Management, Inc. BlackRock Japan Co., Ltd. BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock (Luxembourg) S.A. BlackRock Investment Management (Australia) Limited BlackRock Fund Advisors BlackRock Fund Managers Ltd *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BLACKROCK, INC., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Christopher Meade, Daniel Waltcher, Una Neary, Richard Cundiff, Charles Park, Enda McMahon, Arlene Klein, Con Tzatzakis, Karen Clark, David Maryles, Daniel Ronnen, John Stelley, Daniel Riemer, Elizabeth Kogut, Maureen Gleeson, Daniel Kalish and Spencer Fleming acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company individually or as representative of others, any and all documents, is acting certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, Including without limitation Forms 3, 4, 5, 13D, 13F, 13G and 13H and any amendments to any of the Foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 8th day of December, 2015 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 2nd day of January, 2019. BLACKROCK, INC. By:_ /s/ Daniel Waltcher Name: Daniel Waltcher Title: Deputy General Counsel
    Get the next $AQUA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AQUA

    DatePrice TargetRatingAnalyst
    11/16/2022Outperform → Perform
    Oppenheimer
    1/20/2022$45.00Perform → Outperform
    Oppenheimer
    1/4/2022Outperform → Market Perform
    Raymond James
    11/17/2021$45.00 → $53.00Buy
    Stifel
    11/17/2021$39.00 → $48.00Neutral
    Citigroup
    11/17/2021$42.00 → $50.00Outperform
    Credit Suisse
    11/17/2021$44.00 → $51.00Outperform
    RBC Capital
    11/3/2021Perform
    Oppenheimer
    More analyst ratings

    $AQUA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evoqua Water downgraded by Oppenheimer

    Oppenheimer downgraded Evoqua Water from Outperform to Perform

    11/16/22 7:19:43 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    Evoqua Water Technologies upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Evoqua Water Technologies from Perform to Outperform and set a new price target of $45.00

    1/20/22 6:37:30 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    Evoqua Water Technologies downgraded by Raymond James

    Raymond James downgraded Evoqua Water Technologies from Outperform to Market Perform

    1/4/22 5:14:48 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    $AQUA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sloat Julia A

    4 - Evoqua Water Technologies Corp. (0001604643) (Issuer)

    5/26/23 4:46:19 PM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Swann Lynn C

    4 - Evoqua Water Technologies Corp. (0001604643) (Issuer)

    5/26/23 4:47:23 PM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Wilver Peter M

    4 - Evoqua Water Technologies Corp. (0001604643) (Issuer)

    5/26/23 4:48:12 PM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    $AQUA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TortoiseEcofin Announces Constituent Change Due to Merger and Acquisition Activity

    LEAWOOD, KS / ACCESSWIRE / May 25, 2023 / TortoiseEcofin today announced that Evoqua Water Technologies Corp (NYSE:AQUA) will be removed from the Ecofin Global Water ESG IndexSM (EGWESG) as a result of the approved merger with Xylem Inc (NYSE:XYL). Due to the merger, AQUA will be removed from the index at market open on Friday, May 26, 2023.As per index methodology, AQUA will be removed without a special rebalancing from Ecofin Global Water ESG IndexSM (EGWESG).About TortoiseEcofinTortoiseEcofin focuses on essential assets - those assets and services that are indispensable to the economy and society. We strive to make a positive impact on clients and communities by investing in energy infras

    5/25/23 10:15:00 AM ET
    $AQUA
    $TPZ
    $XYL
    Industrial Machinery/Components
    Industrials
    Investment Managers
    Finance

    Evoqua Water Technologies Reports Second Quarter 2023 Results

    Second Quarter 2023 Financial Highlights: Revenue of $477.8 million, an increase of 12.0% compared to the prior year period; organic revenue growth of 11.6% Net income of $10.6 million, an increase of 43.2% compared to the prior year period Adjusted EBITDA of $88.5 million, an increase of 20.9% compared to the prior year period Evoqua Water Technologies (NYSE:AQUA), an industry leader in mission-critical water treatment solutions, today reported results for its second quarter ended March 31, 2023. Revenue for the second quarter of fiscal year 2023 was $477.8 million, compared to $426.7 million in the prior year period, an increase of 12.0%, or $51.1 million. Organic revenue gr

    5/2/23 7:00:00 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    Evoqua to Release Second Quarter 2023 Financial Results on May 2, 2023

    Evoqua Water Technologies Corp. (NYSE:AQUA) announced plans to release financial results for its second quarter on Tuesday, May 2, 2023. In light of the proposed transaction with Xylem Inc., the company will not hold the customary earnings call and Q&A session to discuss its financial results. However, a modified earnings presentation will be posted on the Investor Relations section of Evoqua's website at https://aqua.evoqua.com on the morning of May 2, 2023. Questions regarding the second quarter financial results should be directed to the company's Investor Relations contact. It is important to note that the company cannot comment on the transaction and will not provide forward-lookin

    4/6/23 7:00:00 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    $AQUA
    SEC Filings

    View All

    SEC Form 15-12G filed by Evoqua Water Technologies Corp.

    15-12G - Evoqua Water Technologies Corp. (0001604643) (Filer)

    6/5/23 2:28:26 PM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    SEC Form EFFECT filed by Evoqua Water Technologies Corp.

    EFFECT - Evoqua Water Technologies Corp. (0001604643) (Filer)

    6/1/23 12:15:05 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    SEC Form POS AM filed by Evoqua Water Technologies Corp.

    POS AM - Evoqua Water Technologies Corp. (0001604643) (Filer)

    5/24/23 9:50:55 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    $AQUA
    Financials

    Live finance-specific insights

    View All

    Evoqua to Release Second Quarter 2023 Financial Results on May 2, 2023

    Evoqua Water Technologies Corp. (NYSE:AQUA) announced plans to release financial results for its second quarter on Tuesday, May 2, 2023. In light of the proposed transaction with Xylem Inc., the company will not hold the customary earnings call and Q&A session to discuss its financial results. However, a modified earnings presentation will be posted on the Investor Relations section of Evoqua's website at https://aqua.evoqua.com on the morning of May 2, 2023. Questions regarding the second quarter financial results should be directed to the company's Investor Relations contact. It is important to note that the company cannot comment on the transaction and will not provide forward-lookin

    4/6/23 7:00:00 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    Evoqua Water Technologies Acquires the Industrial Water Service Business of the Former Bob Johnson & Associates from Kemco Systems, Expanding Its Presence in Texas

    Evoqua Water Technologies (NYSE:AQUA), an industry leader in mission-critical water treatment solutions, today announced that it has acquired the Texas-based industrial water treatment service business of the former Bob Johnson & Associates from Kemco Systems, further strengthening Evoqua's service footprint in the Texas market. The deal includes the industrial water treatment service business accounts for the Houston and Waxahachie, Texas regions as well as its deionization (DI) and carbon tank assets. The terms of the deal were not disclosed. "This acquisition will expand our service and aftermarket business in the Texas market while strengthening our ability to better support and serve

    3/1/23 7:00:00 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    Evoqua Water Technologies Reports First Quarter 2023 Results

     First Quarter 2023 Financial Highlights: Revenue of $435.8 million, an increase of 19.0% compared to the prior year period; organic revenue growth of 9.1% Net income of $9.3 million, an increase of 52.5% compared to the prior year period Adjusted EBITDA of $72.7 million, an increase of 33.9% compared to the prior year period Evoqua Water Technologies (NYSE:AQUA), an industry leader in mission-critical water treatment solutions, today reported results for its first quarter ended December 31, 2022. Revenue for the first quarter of fiscal year 2023 was $435.8 million, compared to $366.3 million in the prior year period, an increase of 19.0%, or $69.5 million. Organic revenue growth c

    1/31/23 7:00:00 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    $AQUA
    Leadership Updates

    Live Leadership Updates

    View All

    Evoqua Water Technologies Appoints Julia Sloat to its Board of Directors

    Evoqua Water Technologies (NYSE:AQUA), an industry leader in mission-critical water treatment solutions, today announced the appointment of Julia (Julie) Sloat to its Board of Directors. Ms. Sloat will serve as an independent director and a member of the company's Audit Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220301005039/en/Julia (Julie) Sloat appointed to Evoqua Water Technologies Board of Directors (Photo: Business Wire) "We are pleased to welcome Julie to our Board of Directors," said Ron Keating, Evoqua's Chief Executive Officer. "Julie brings a wealth of relevant and strong leadership in corporate finance,

    3/1/22 4:15:00 PM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    Evoqua Water Technologies Appoints Sherrese Clarke Soares to Its Board of Directors

    Evoqua Water Technologies (NYSE:AQUA), a leader in mission-critical water treatment solutions, today announced the appointment of Sherrese Clarke Soares to its Board of Directors. Ms. Clarke Soares will serve as an independent director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210818005656/en/Sherrese Clarke Soares appointed to Evoqua Water Technologies Board of Directors (Photo: Business Wire) "We are pleased to welcome Sherrese to Evoqua's Board of Directors," said Ron Keating, Evoqua's Chief Executive Officer. "Sherrese is a seasoned financial services executive who brings extensive experience in corporate finance and i

    8/18/21 4:15:00 PM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    $AQUA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Evoqua Water Technologies Corp. (Amendment)

    SC 13G/A - Evoqua Water Technologies Corp. (0001604643) (Subject)

    2/1/24 3:37:01 PM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Evoqua Water Technologies Corp. (Amendment)

    SC 13G/A - Evoqua Water Technologies Corp. (0001604643) (Subject)

    2/3/23 1:06:59 PM ET
    $AQUA
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Evoqua Water Technologies Corp. (Amendment)

    SC 13G/A - Evoqua Water Technologies Corp. (0001604643) (Subject)

    1/31/23 9:19:10 AM ET
    $AQUA
    Industrial Machinery/Components
    Industrials